Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 128 Colonic Neoplasms 54 Rectal Neoplasms 49 Carcinoma, Hepatocellular 29 Stomach Neoplasms 23 Neoplasm Metastasis 22 Neoplasms 11 Pancreatic Neoplasms 10 Cholangiocarcinoma 9 Adenocarcinoma Of Esophagus 8 Esophageal Neoplasms 7 Liver Neoplasms 6 Gastrointestinal Neoplasms 5 Biliary Tract Neoplasms 5 Recurrence 4 Ovarian Neoplasms 4 Esophageal Squamous Cell Carcinoma 3 Digestive System Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Adenocarcinoma 3 Unresectable Metastatic Colorectal Cancer 2 Peritoneal Neoplasms 2 Neurotoxicity Syndromes 2 Neoplastic Cells, Circulating 2 Intestinal Neoplasms 2 Gastrointestinal Diseases 2 Gallbladder Neoplasms 2 Colorectal Cancer Metastatic 2 Cirrhosis, Familial, with Pulmonary Hypertension 2

Interventions

Oxaliplatin 1 Folfox protocol 1 Capecitabine 1 ASTX-660 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Locally-advanced Rectal Cancer × Folfox protocol × Clear all

NCT05912075 2024-02-08

PRAAR1

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Recruiting

Gastrointestinal

Locally-advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡